Author Archive: Jeremy Parkinson

US Dollar Drops To August Lows – Is The Bullish Trend Finished?

US Dollar Drops To August Lows – Is The Bullish Trend Finished?

Talking Points The US Dollar has fallen-below the bullish trend-line that has supported prices over the past two months, and we’re now seeing sellers test August lows in the currency around 94.50. The big driver here appears to be the recovery in EUR/USD, as the pair has now recovered the entirety of the prior August losses, […]
US Recession Risk Is Low, According To Current Q3 GDP Estimates

US Recession Risk Is Low, According To Current Q3 GDP Estimates

The flattening yield curve has sparked worries that a new recession is near, but the near-term outlook for growth still looks healthy, based on the latest set of nowcasts for third quarter GDP, as compiled by The Capital Spectator. The median estimate points to a solid 3.3% increase for Q3 output. Although that’s down from […]
Technically Speaking: The Bull Market Resumes…For Now

Technically Speaking: The Bull Market Resumes…For Now

Back in April, I penned an article laying out 10-reasons why from a fundamental and technical perspective the bull market may have ended. To wit: “I think the 9-year old bull market may have ended in February. I could be wrong. Actually, I hope that I am because managing money is far easier when markets are rising.” […]
Anticipating How Welcome This Second Deluge Will Be

Anticipating How Welcome This Second Deluge Will Be

Effective federal funds (EFF) was 1.92% again yesterday. That’s now eight in a row just 3 bps underneath the “technically adjusted” IOER. If indeed the FOMC has to make another one to this tortured tool we know already who will be blamed for it. The Treasury Department announced yesterday that it will be auctioning off […]
Global Trade Indicators Improve

Global Trade Indicators Improve

The official trade reports take a few months to come out which is why I can only can say growth slowed from the beginning of the year to May. The official numbers are very important, but if you want up to the minute results, you can review the indicators below. As you can see, it […]
Stocks And Precious Metals Charts – Same As It Ever Was

Stocks And Precious Metals Charts – Same As It Ever Was

Today was a precious metals option expiration on the Comex. Both gold and silver took a bit of a hit, as the dollar was largely unchanged. Stocks went sideways. The conversations about the economy and the political situation went sideways as well. As a reminder, we are going to have a three day weekend here in the […]
August Regional Fed Manufacturing Overview

August Regional Fed Manufacturing Overview

Five out of the twelve Federal Reserve Regional Districts currently publish monthly data on regional manufacturing: Dallas, Kansas City, New York, Richmond, and Philadelphia. Regional manufacturing surveys are a measure of local economic health and are used as a representative for the larger national manufacturing health. They have been used as a signal for business uncertainty and […]
Tiffany (TIF) Stock Up On Q2 Earnings Beat And Higher View

Tiffany (TIF) Stock Up On Q2 Earnings Beat And Higher View

Tiffany & Co. TIF reported second-quarter fiscal 2018 results, which marked the company’s fifth straight quarter of positive earnings and sales surprises. Moreover, both the top and bottom lines continue to improve year over year. The solid results also called for an upbeat earnings view for fiscal 2018. In fact, the stock has gained 47% in a […]
IMMU: Why This Biotech Could Go Crazy In 2019

IMMU: Why This Biotech Could Go Crazy In 2019

Clinical-stage biopharma Immunomedics (Nasdaq:IMMU) is a heavyweight player soaring in the worldwide antibody-drug conjugate (ADC) market. In other words, IMMU specializes in cancer therapies; and it’s been a standout year for investors. Notably, IMMU’s lead investigational ADC is IMMU-132 (sacituzumab govitecan), designed for heavily pre-treated patients with ER+ and HER2-metastatic breast cancer. It’s been a […]
Yum China Rises After Reportedly Spurning $46 Per Share Takeover Bid

Yum China Rises After Reportedly Spurning $46 Per Share Takeover Bid

Shares of Yum China (YUMC) are on the rise following a media report saying the company has rejected a buyout offer of $46 per share made by a consortium led by Hillhouse Capital. Earlier this month, Bloomberg had reported that China’s sovereign wealth fund, China Investment Corp., was part of the consortium bidding to take […]